Business Strategy

  • Home
  • Business Strategy
Strategic Framework

The Market Entry Roadmap

Our market entry strategy framework encompasses several specialized services structured to de-risk internationalization in the Pharmaceutical Space. With our internal pharma bandwidth, we assess, analyze, and determine the optimal entry strategy for each target territory, prioritizing execution in a phased and compliant manner.

Phase A: Market Assessment

Before allocating capital, we analyze the micro and macro environment. Market assessment evaluates licensing regulations, customer demand metrics, and competitor postures.

Regulatory Assessment
  • What licenses are required and for which business models?
  • What are the geographic limitations or renewal terms?
  • What are the regulatory registration costs and timings?
  • What entry structures are permitted (e.g., JV, subsidiary)?
Customer & Therapy Area Assessment
  • What therapy segments exist, and what are their relative sizes?
  • What are the unmet medical needs today and in the future?
  • What are the key prescription criteria for local doctors?
  • What influences purchasing decisions in the hospitals?
Competitive Assessment
  • How large is the market size projection over 5 to 10 years?
  • What are the critical barriers to entry and impediments?
  • Who are the key competitors, and what is their strategy?
  • What product categories and pricing models do they offer?
Distribution & Channel Assessment
  • What distribution channels are active, and who are the wholesalers?
  • What are their commercial margins and credit conditions?
  • How flows the supply chain from customs to local point of care?
  • What logistics and cold chain infrastructures are available?

Phase B: Business Case Development

Translating data into commercial parameters. We formulate formal proposals justifying capital deployment and defining return profiles.

  • Select optimal corporate structures (e.g. Joint Ventures, representative agents).
  • Establish financial feasibility, pricing structures, and commercial margins.
  • Perform strategic tax planning, pricing audits, and operational forecasts.

Phase C: Implementation Road Map

Establishing the tactical rollout. We draft detailed milestone lists, licensing timelines, and critical path activities.

  • Set chronologically aligned task lists and assign operational milestones.
  • Submit initial files to regional drug directorates and secure permits.
  • Auditing local warehouse space, cold storage setups, and secondary packaging channels.

Phase D: Go Live

Execution, launching, and scaling. We coordinate formulation arrivals, support marketing teams, and maintain regulatory health checks.

  • Launching products under commercial distributor networks.
  • Audit initial clinical customer reviews, medical channel volumes, and margins.
  • Maintain compliance reviews to secure long-term regulatory license status.

Let's Build Your Roadmap Together

Whether you are analyzing a single therapy sector or seeking WHO-GMP facility licensing, our phased frameworks are built to deliver success.

Initiate Assessment Phase